FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Euclidean Capital LLC
2. Date of Event Requiring Statement (MM/DD/YYYY)
4/28/2021 

3. Issuer Name and Ticker or Trading Symbol

PMV Pharmaceuticals, Inc. [PMVP]
(Last)        (First)        (Middle)

160 FIFTH AVE, 9TH FL, 
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          ___X___ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)
(Street)

NEW YORK, NY 10010      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 693769 I See footnotes (1)(6)
Common Stock 2601637 I See footnotes (2)(6)
Common Stock 751409 I See footnotes (3)(6)
Common Stock 132601 I See footnotes (4)(6)
Common Stock 494407 I See footnotes (5)(6)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:
(1) The shares are held of record by Greenland A LLC, which is managed by Euclidean Capital LLC ("Euclidean"). Marilyn Simons and James Simons are owners and managers of Euclidean, and Ashvin Chhabra is President, CIO and Manager of Euclidean.
(2) The shares are held of record by Greenland NFP B Ltd., which is managed by Euclidean.
(3) The shares are held of record by Greenland FP LLC, which is managed by Euclidean.
(4) The shares are held of record by Greenland NFP LLC, which is managed by Euclidean.
(5) The shares are held of record by Symmetry Group Ltd ("Symmetry"). Mrs. Simons and Mr. Simons are on the board of directors of Symmetry's parent.
(6) Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 3, except to the extent of any pecuniary interest therein.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Euclidean Capital LLC
160 FIFTH AVE, 9TH FL
NEW YORK, NY 10010

X

Greenland A LLC
C/O EUCLIDEAN CAPITAL LLC
160 FIFTH AVE, 9TH FL
NEW YORK, NY 10010

X

Greenland FP LLC
C/O EUCLIDEAN CAPITAL LLC
160 FIFTH AVE, 9TH FL
NEW YORK, NY 10010

X

Greenland NFP B Ltd.
C/O EUCLIDEAN CAPITAL LLC
160 FIFTH AVE, 9TH FL
NEW YORK, NY 10010

X

Greenland NFP LLC
C/O EUCLIDEAN CAPITAL LLC
160 FIFTH AVE, 9TH FL
NEW YORK, NY 10010

X

Symmetry Group Ltd.
C/O EUCLIDEAN CAPITAL LLC
160 FIFTH AVE, 9TH FL
NEW YORK, NY 10010

X

Simons Marilyn
C/O EUCLIDEAN CAPITAL LLC
160 FIFTH AVE, 9TH FL
NEW YORK, NY 10010

X

Chhabra Ashvin
C/O EUCLIDEAN CAPITAL LLC
160 FIFTH AVE, 9TH FL
NEW YORK, NY 10010

X

SIMONS JAMES H
C/O EUCLIDEAN CAPITAL LLC
160 FIFTH AVE, 9TH FL
NEW YORK, NY 10010

X


Signatures
/s/ Joseph Cosmai - Euclidean Capital LLC, By: Joseph Cosmai, Manager5/7/2021
**Signature of Reporting PersonDate

/s/ Joseph Cosmai - Greenland A LLC, By: Joseph Cosmai, Manager of Euclidean Capital LLC, its Manager5/7/2021
**Signature of Reporting PersonDate

/s/ Joseph Cosmai - Greenland FP LLC, By: Joseph Cosmai, Manager of Euclidean Capital LLC, its Manager5/7/2021
**Signature of Reporting PersonDate

/s/ Joseph Cosmai - Greenland NFP B Ltd., By: Joseph Cosmai, Manager of Euclidean Capital LLC, its Manager5/7/2021
**Signature of Reporting PersonDate

/s/ Joseph Cosmai - Greenland NFP LLC, By: Joseph Cosmai, Manager of Euclidean Capital LLC, its Manager5/7/2021
**Signature of Reporting PersonDate

/s/ Jane Malone - Symmetry Group Ltd., By: Jane Malone, Officer of H.T.M. Services Ltd., its Director5/7/2021
**Signature of Reporting PersonDate

/s/ Iona Gordon - Symmetry Group Ltd., By: Iona Gordon, Officer of H.T.M. Services Ltd., its Director5/7/2021
**Signature of Reporting PersonDate

/s/ Marilyn Simons5/7/2021
**Signature of Reporting PersonDate

/s/ Ashvin Chhabra5/7/2021
**Signature of Reporting PersonDate

/s/ James Simons5/7/2021
**Signature of Reporting PersonDate

PMV Pharmaceuticals (NASDAQ:PMVP)
過去 株価チャート
から 6 2024 まで 7 2024 PMV Pharmaceuticalsのチャートをもっと見るにはこちらをクリック
PMV Pharmaceuticals (NASDAQ:PMVP)
過去 株価チャート
から 7 2023 まで 7 2024 PMV Pharmaceuticalsのチャートをもっと見るにはこちらをクリック